Company Overview and News

 
TCS Q4 results: Company all set to hit $100 billion market capitalisation mark

13h freepressjournal.in
Mumbai: Shares of IT bellwether Tata Consultancy Services (TCS) on Friday rose over 7 percent to touch a new high of Rs 3,419.80 per share, taking its market capitalisation (m-cap) to over Rs 6.50 lakh crore or around $98 billion. With this, the IT major emerges as the first Indian company with a market capitalisation of close to $100 billion. On closing (at 3.30 p.m.), the m-cap of the company stood at Rs 6,53,154.
Upvote Downvote

 
Market Update: Hindalco, Vedanta jump 7% as CNX Metal outperforms; UltraTech, Yes Bank top gainers

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 29 points was trading at 10,555 while the Sensex was up 63 points or 0.18 percent.
Upvote Downvote

 
Market Update: Metal stocks outshine as NALCO, Hindustan Copper jump 9-12%; HUL hits new 52-week high

2018-04-19 moneycontrol
The Indian equity market was trading on a positive note on Thursday afternoon with the Nifty gaining 33 points was trading at 10,560 while the Sensex was up 65 points or 0.19 percent.
Upvote Downvote

 
Market Update: FMCG, realty space outperforms led by Godrej Properties, ITC; Infosys, ICICI most active

2018-04-18 moneycontrol
The Indian equity market was trading flat on Wednesday afternoon with the Nifty marginally up and was trading at 10,554 while the Sensex was up 26 points or 0.08 percent.
Upvote Downvote

 
Market Update: Nifty Pharma gains led by Cipla, Divi#39;s Labs; Zee Entertainment up 2%, DHFL most active

2018-04-18 moneycontrol
The Indian equity market was trading flat on Wednesday morning with the Nifty marginally down and was trading at 10,548 while the Sensex was down 7 points.
Upvote Downvote

 
Hotel Leelaventure defaults on NCD interest to LIC

2018-04-17 thehindubusinessline
Our Bureau Hotel Leelaventure on Tuesday said that it has defaulted on interest and principal payments since 2016, on the ₹90-crore non-convertible debentures issued to Life Insurance Corporation of India.
Upvote Downvote

 
UTI Mutual files paper for Equity Savings Fund

2018-04-17 thehindubusinessline
Our Bureau UTI Mutual Fund has filed a draft paper with SEBI for UTI Equity Savings Fund.
Upvote Downvote

 
M&M joins ₹1-trillion m-cap club

2018-04-17 thehindubusinessline
Our Bureau For the shares of Mahindra & Mahindra, it was a dream day as they entered the prestigious ₹1 lakh crore market capitalisation club after the stock settled with gains of over 1 per cent.
Upvote Downvote

 
Global markets: Sterling, metals shine brightest as risk appetite returns

2018-04-17 thehindubusinessline
The pound’s rise was its eighth in a row, coming as bets firm on another Bank of England rate hike next month, while yields on US Treasuries were at their highest in over three weeks ahead of a flurry of top Fed speakers.
Upvote Downvote

 
Bharat-22 ETF follow-on offer could be worth ₹10,000 cr

2018-04-17 thehindubusinessline
The Finance Ministry may come out with a ₹10,000-crore follow-on fund offer of the Bharat-22 exchange traded fund (ETF) as it looks to dilute stake in Coal India to meet the minimum public holding norm.
Upvote Downvote

 
European shares edge up as sentiment improves

2018-04-17 thehindubusinessline
The pan-regional STOXX 600 index was up 0.1 per cent by 0740 GMT, while other European benchmarks were also trading in positive territory, catching up slightly with a strong close on Wall Street. - REUTERS
Upvote Downvote

 
Market Update: Nifty Realty outperforms led by Godrej Properties; ICICI, HDFC Bank gain, DHFL most active

2018-04-17 moneycontrol
The Indian equity market was trading on a positive note on Tuesday morning with the Nifty adding 18 points and was trading at 10,546 while the Sensex was up 80 points or 0.23 percent.
Upvote Downvote

 
Capricorn Food gets SEBI nod to launch IPO

2018-04-17 thehindubusinessline
Capricorn Food Products India Ltd, an integrated food processing company, has received SEBI nod to float an initial public offering.
Upvote Downvote

 
HUL shares touch record high of Rs 1,438

2018-04-17 thehindubusinessline
HUK stock is in a strong uptrend with the Trend Intensity indicator showing a reading of 31
Upvote Downvote

 
Market Update: TCS, Wipro shed 1% as CNX IT drags; Power Grid top gainer, Bharti Infratel down 2%

2018-04-17 moneycontrol
The Indian equity market slipped into the red on Tuesday afternoon with the Nifty shedding 23 points and was trading just above the 10,500 mark at 10,505 while the Sensex was down 44 points or 0.13 percent.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...